Publication: Prolonged treatment with boosted protease inhibitor monotherapy is not associated with a higher rate of neurocognitive impairment than triple drug ART
| dc.contributor.author | Pérez-Valero, I | |
| dc.contributor.author | González-Baeza, A | |
| dc.contributor.author | Estébanez, M | |
| dc.contributor.author | Montes, M | |
| dc.contributor.author | Bayon, C | |
| dc.contributor.author | Pulido, F | |
| dc.contributor.author | Cambrón, I | |
| dc.contributor.author | Bernardino, J | |
| dc.contributor.author | Zamora, F | |
| dc.contributor.author | Monge Corella, Susana | |
| dc.contributor.author | Gaya, F | |
| dc.contributor.author | Lagarde, M | |
| dc.contributor.author | Rubio, R | |
| dc.contributor.author | Hernando, A | |
| dc.contributor.author | González-García, Juan | |
| dc.contributor.author | Arnalich, F | |
| dc.contributor.author | Arribas, José R | |
| dc.date.accessioned | 2021-04-29T10:38:04Z | |
| dc.date.available | 2021-04-29T10:38:04Z | |
| dc.date.issued | 2012-11 | |
| dc.description | Eleventh International Congress on Drug Therapy in HIV Infection, 11-15 November 2012, Glasgow, UK. | |
| dc.description.peerreviewed | Sí | es_ES |
| dc.format.number | 6 (Suppl 4) | es_ES |
| dc.format.volume | 15 | es_ES |
| dc.identifier.citation | J Int AIDS Soc. 2012 Nov 11;15 Suppl 4(Suppl 4):18179. | es_ES |
| dc.identifier.doi | 10.7448/IAS.15.6.18179 | es_ES |
| dc.identifier.e-issn | 1758-2652 | es_ES |
| dc.identifier.journal | Journal of the International AIDS Society | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/12821 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Wiley | |
| dc.relation.publisherversion | http://dx.doi.org/10.7448/IAS.15.6.18179 | es_ES |
| dc.repisalud.centro | ISCIII::Centro Nacional de Epidemiología | es_ES |
| dc.repisalud.institucion | ISCIII | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.title | Prolonged treatment with boosted protease inhibitor monotherapy is not associated with a higher rate of neurocognitive impairment than triple drug ART | es_ES |
| dc.type | conference paper | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | a0bb4f4f-11f0-487e-bf93-0b13f90057cc | |
| relation.isAuthorOfPublication.latestForDiscovery | a0bb4f4f-11f0-487e-bf93-0b13f90057cc | |
| relation.isPublisherOfPublication | d81e762a-95f7-4917-88a1-8004b3b8caa7 | |
| relation.isPublisherOfPublication.latestForDiscovery | d81e762a-95f7-4917-88a1-8004b3b8caa7 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ProlongedTreatmentWithBoosted_2012.pdf
- Size:
- 182.73 KB
- Format:
- Adobe Portable Document Format
- Description:


